David A. Siegel Merrimack Pharmaceuticals Inc Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

Shares

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	SELL	$3.68 - $12.51 $27,600 - $93,825	-7,500 Reduced 40.15%	11,181 $128,000
Q3 2022 Nov 14, 2022	SELL	$3.7 - $6.06 $1,110 - $1,817	-300 Reduced 1.58%	18,681 $70,000
Q2 2022 Aug 15, 2022	SELL	$4.89 - $7.13 $20,538 - $29,946	-4,200 Reduced 18.12%	18,981 $113,000
Q1 2022 May 16, 2022	SELL	$3.75 - $6.82 $9,375 - $17,050	-2,500 Reduced 9.73%	23,181 $147,000
Q4 2021 Feb 14, 2022	SELL	$3.75 - $5.1 $25,500 - $34,680	-6,800 Reduced 20.94%	25,681 $100,000
Q3 2021 Nov 15, 2021	SELL	$4.3 - $6.39 $41,645 - $61,887	-9,685 Reduced 22.97%	32,481 $157,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $7.77 $701,117 - $901,933	-116,079 Reduced 73.35%	42,166 $269,000
Q1 2021 May 17, 2021	SELL	$6.15 - $8.7 $380,469 - $538,225	-61,865 Reduced 28.11%	158,245 $994,000
Q4 2020 Feb 16, 2021	BUY	$3.69 - $8.31 $812,205 - $1.83 Million	220,110 New	220,110 $1.52 Million

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.